Literature DB >> 17546572

A quantitative approach to benefit-risk assessment of medicines--part 1: the development of a new model using multi-criteria decision analysis; part 2: the practical application of a new model.

Filip Mussen, Sam Salek, Stuart Walker.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17546572     DOI： 10.1002/pds.1436

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  4 in total

1.  Net clinical benefit of oral anticoagulants: a multiple criteria decision analysis.

Authors:  Jason C Hsu; Cheng-Yang Hsieh; Yea-Huei Kao Yang; Christine Y Lu
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

Review 2.  Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.

Authors:  Mireille M Goetghebeur; Monika Wagner; Hanane Khoury; Randy J Levitt; Lonny J Erickson; Donna Rindress
Journal:  BMC Health Serv Res       Date:  2008-12-22       Impact factor: 2.655

3.  Selecting the Acceptance Criteria of Medicines in the Reimbursement List of Public Health Insurance of Iran, Using the "Borda" Method: a Pilot Study.

Authors:  Amir Viyanchi; Hamid Reza Rasekh; Ali Rajabzadeh Ghatari; Hamid Reza SafiKhani
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

4.  Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis.

Authors:  Jose Mendoza-Sanchez; Federico Silva; Lady Rangel; Linda Jaramillo; Leidy Mendoza; Jenny Garzon; Andrea Quiroga
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.